In a report published Thursday, Credit Suisse analyst Michael Steib reiterated an Underperform rating on Clorox Co. CLX, and raised the price target from $90.00 to $102.00.
In the report, Credit Suisse noted, "CLX posted 2Q15 results today that showed a strong acceleration from prior quarters and beat expectations. The biggest surprise was 5.7% organic sales growth, well ahead of CLX's category growth, and, while helped by some one-offs, all segments accelerated. Leverage from higher sales along with cost savings allowed the company to expand EBIT margin by 40bps despite Street expectations for a YoY decline given higher brand investments, commodity and FX headwinds. We adjust our estimates ~1% and increase our TP to $102."
Clorox closed on Wednesday at $109.61.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in